# Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis

> **NCT06569472** · PHASE1 · RECRUITING · sponsor: **Chongqing Precision Biotech Co., Ltd** · enrollment: 10 (estimated)

## Conditions studied

- Juvenile Dermatomyositis

## Interventions

- **BIOLOGICAL:** CD19-targetd CAR-T

## Key facts

- **NCT ID:** NCT06569472
- **Lead sponsor:** Chongqing Precision Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-02
- **Primary completion:** 2027-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2024-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06569472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06569472, "Clinical Trial of CD19-targeted CAR-T Therapy for Refractory Juvenile Dermatomyositis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06569472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*